Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?
Viruses · 2023
DOI: 10.3390/v15071451 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Chuan-Han Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Ta…. Hauptthemen laut MEDLINE: COVID-19, Virus Diseases, Zika Virus, Zika Virus Infection. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macau Science and Technology Development Fund, Shenzhen-Hong Kong-Macao Science and Technology Innovation Project (Category C), Science and Technology Development Fund of Macau.
Abstract (Originalsprache)
Inflammasome activation is exclusively involved in sensing activation of innate immunity and inflammatory response during viral infection. Accumulating evidence suggests that the manipulation of inflammasome assembly or its interaction with viral proteins are critical factors in viral pathogenesis. Results from pilot clinical trials show encouraging results of NLRP3 inflammasome suppression in reducing mortality and morbidity in SARS-CoV-2-infected patients. In this article, we summarize the up-to-date understanding of inflammasomes, including NLRP3, AIM2, NLRP1, NLRP6, and NLRC4 in various viral infections, with particular focus on RNA viruses such as SARS-CoV-2, HIV, IAV, and Zika virus and DNA viruses such as herpes simplex virus 1. We also discuss the current achievement of the mechanisms involved in viral infection-induced inflammatory response, host defense, and possible therapeutic solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
- State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Av. Wai Long, Taipa, Macao 999078, China.
- Cancer Centre, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China.
- MoE Frontiers Science Center for Precision Oncology, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
- Department of Pharmaceutical Sciences, Faculty of Health Science, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
- Minister of Education Key Laboratory of Tumor Molecular Biology, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Chuan-Han Deng, Qi Zhao, Ying Wang
Förderung
- Macau Science and Technology Development Fund
- Shenzhen-Hong Kong-Macao Science and Technology Innovation Project (Category C)
- Science and Technology Development Fund of Macau
- University of Macau
- Natural Science Foundation of Guangdong Province
- Zhongnanshan Medical Foundation of Guangdong Province
Zitieren
APA
Deng, C. H., Li, T. Q., Zhang, W., Zhao, Q., & Wang, Y. (2023). Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?. Viruses. https://doi.org/10.3390/v15071451
Vancouver
Deng CH, Li TQ, Zhang W, Zhao Q, Wang Y. Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?. Viruses. 2023. doi:10.3390/v15071451
BibTeX
@article{Deng2023,
author = {Deng, Chuan-Han and Li, Tian-Qi and Zhang, Wei and Zhao, Qi and Wang, Ying},
title = {Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15071451}
}
EUVIMED